TipRanks
Advertisement
Advertisement

ZBIO Stock Latest News

Zenas BioPharma announces new data from Phase 3 INDIGO trial on obexelimab
The FlyZenas BioPharma announces new data from Phase 3 INDIGO trial on obexelimab
7d ago
ZBIO
Wedbush biotech analyst holds an analyst/industry conference call
PremiumThe Fly
Wedbush biotech analyst holds an analyst/industry conference call
8d ago
MLTX
ORKA
Zenas BioPharma files to sell 7.0M shares of common stock for holders
PremiumThe Fly
Zenas BioPharma files to sell 7.0M shares of common stock for holders
17d ago
ZBIO
Zenas BioPharma price target raised to $32 from $22 at Morgan Stanley
PremiumThe Fly
Zenas BioPharma price target raised to $32 from $22 at Morgan Stanley
1M ago
ZBIO
Zenas BioPharma reports Q2 EPS ($1.77), consensus (75c)
PremiumThe Fly
Zenas BioPharma reports Q2 EPS ($1.77), consensus (75c)
1M ago
ZBIO
Zenas BioPharma CFO Jennifer Fox to transition out of role
PremiumThe FlyZenas BioPharma CFO Jennifer Fox to transition out of role
1M ago
ZBIO
Zenas BioPharma price target raised to $32 from $22 at Morgan Stanley
Premium
The Fly
Zenas BioPharma price target raised to $32 from $22 at Morgan Stanley
1M ago
ZBIO
Court Dismisses Securities Lawsuit Against Zenas BioPharma Over IPO Disclosures 
Premium
Class Action
Court Dismisses Securities Lawsuit Against Zenas BioPharma Over IPO Disclosures 
3M ago
ZBIO
Zenas BioPharma submits BLA to FDA for obexelimab
PremiumThe Fly
Zenas BioPharma submits BLA to FDA for obexelimab
4M ago
ZBIO
Insiders Buy the Dip in These 2 Crushed Stocks With Strong Buy Ratings
PremiumMarket News
Insiders Buy the Dip in These 2 Crushed Stocks With Strong Buy Ratings
4M ago
NIQ
ZBIO
Zenas BioPharma Advances Phase 3 Orelabrutinib Trial in Tough MS Segment
PremiumCompany Announcements
Zenas BioPharma Advances Phase 3 Orelabrutinib Trial in Tough MS Segment
4M ago
ZBIO
Zenas BioPharma price target raised to $22 from $21 at Morgan Stanley
PremiumThe Fly
Zenas BioPharma price target raised to $22 from $21 at Morgan Stanley
5M ago
ZBIO
Citi opens ‘upside 30-day catalyst watch’ on Zenas BioPharma
PremiumThe FlyCiti opens ‘upside 30-day catalyst watch’ on Zenas BioPharma
5M ago
ZBIO
Zenas BioPharma doses first patient in Phase 1 clinical trial of ZB021
Premium
The Fly
Zenas BioPharma doses first patient in Phase 1 clinical trial of ZB021
5M ago
ZBIO
Zenas BioPharma Highlights Strong Q1 Progress and Financing
Premium
Company Announcements
Zenas BioPharma Highlights Strong Q1 Progress and Financing
5M ago
8K
ZBIO
Zenas BioPharma reports Q1 EPS ($1.46) vs. (80c) last year
PremiumThe Fly
Zenas BioPharma reports Q1 EPS ($1.46) vs. (80c) last year
5M ago
ZBIO
Zenas BioPharma, Inc. (ZBIO) Q1 Earnings Cheat Sheet
PremiumPre-Earnings
Zenas BioPharma, Inc. (ZBIO) Q1 Earnings Cheat Sheet
5M ago
ZBIO
Insiders Are Scooping Up These 2 ‘Strong Buy’ Stocks
PremiumStock Analysis & Ideas
Insiders Are Scooping Up These 2 ‘Strong Buy’ Stocks
6M ago
NAVN
ZBIO
Zenas BioPharma Raises Capital via Notes and Equity Offering
PremiumCompany Announcements
Zenas BioPharma Raises Capital via Notes and Equity Offering
6M ago
8K
ZBIO
Zenas BioPharma director buys $1.5M in common stock
PremiumThe FlyZenas BioPharma director buys $1.5M in common stock
6M ago
ZBIO
Zenas BioPharma 5M share Spot Secondary priced at $20.00
Premium
The Fly
Zenas BioPharma 5M share Spot Secondary priced at $20.00
6M ago
ZBIO
Closing Bell Movers: Argan jumps 10% on earnings beat
Premium
The Fly
Closing Bell Movers: Argan jumps 10% on earnings beat
6M ago
U
AGX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >